Addressing infectious diseases in Africa by accelerating drug discovery through data science
Open Access
- 25 November 2025
- journal article
- review article
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 498
Abstract
Despite being rich in natural resources and scientific talent, Africa continues to bear a staggering infectious disease burden. Historically, health innovation on the continent has relied on international funding and has been constrained by limited infrastructure and the emigration of skilled professionals. Data science tools offer a promising alternative, typically requiring fewer costly resources than traditional empirical research, with the potential to empower African scientists to generate tangible and impactful health solutions for the continent. Rapid progress in data science is expected to transform infectious disease research; thus, it is encouraging that numerous African initiatives are already applying data science tools to tackling pressing unmet medical needs, particularly in drug discovery. These efforts include identifying novel therapeutic targets, predicting drug-like molecules and their synthesis, enhancing clinical trial success rates and preparing for future disease threats. This review examines the current landscape of data science in infectious disease drug discovery across Africa.Keywords
This publication has 89 references indexed in Scilit:
- Advancing pharmacogenetics research in Africa: the “Project Africa GRADIENT” initiativeDrug Discovery Today, 2024
- Artificial intelligence in Africa: a bibliometric analysis from 2013 to 2022Discover Artificial Intelligence, 2023
- An ethnopharmacological survey of medicinal plants traditionally used by the BaKalanga people of the Tutume subdistrict in Central Botswana to manage HIV/AIDS, HIV-associated conditions, and other health conditionsJournal of Ethnopharmacology, 2023
- How good are AlphaFold models for docking-based virtual screening?iScience, 2022
- EBOLApred: A machine learning-based web application for predicting cell entry inhibitors of the Ebola virusComputational Biology and Chemistry, 2022
- Machine learning for artemisinin resistance in malaria treatment across in vivo-in vitro platformsiScience, 2022
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018JAMA, 2020
- A Deep Learning Approach to Antibiotic DiscoveryCell, 2020
- Power outages and firm performance in Sub-Saharan AfricaJournal of Development Economics, 2018
- Overview of Current Drug Discovery Activities in Africa and Their Links to International Efforts to Combat Tropical Infectious Diseases2012